Skip to content

Effect of sildenafil on treatment of oligohydramnios

Comparison of the effectiveness of sildenafil plus hydration therapy with the hydration therapy alone on the treatment of oligohydramnios in pregnant women referring to Arash Hospital

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170917036227N3
Enrollment
52
Registered
2018-07-15
Start date
2017-10-23
Completion date
Unknown
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oligohydramnios. Oligohydramnios

Interventions

Intervention 1: Intervention group: oral sildenafil tablets with a dose of 25 mg every 8 hours along with hydration therapy. Intervention 2: Control group: Hydration therapy alone.

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: singleton pregnancy Gestational age 28 weeks and above Ultrasonically diagnosed oligohydramnios in the third trimester ( defined as Amniotic Fluid Index (AFI) blow 8 cm )

Exclusion criteria

Exclusion criteria: Intrauterine growth restriction (IUGR) Fetal Anomaly Abnormal Blood Flow Patterns by Color Doppler flow imaging Abnormal NST Treatment with Prostaglandin synthetase inhibitors Rupture of membranes Active Labor Chronic Hypertension Overt Diabetes Mellitus Maternal Hydration therapy contraindications ( like renal, respiratory or cardiac diseases )

Design outcomes

Primary

MeasureTime frame
Amniotic fluid index. Timepoint: 24 hours after starting treatment and every week after discharge for up to 6 weeks. Method of measurement: Ultrasonography.

Secondary

MeasureTime frame
Duration of intervention until delivery. Timepoint: During intervention. Method of measurement: check list.;Infant weight. Timepoint: At the end of the study. Method of measurement: Balance (in kilograms and grams).;NICU Admission. Timepoint: At the end of the study. Method of measurement: File information.;APGAR Score. Timepoint: At the end of the study. Method of measurement: File information.;Type of delivery. Timepoint: At the end of the study. Method of measurement: File information.;Gestational Age at birth. Timepoint: At the end of the study. Method of measurement: File information.

Countries

Iran (Islamic Republic of)

Contacts

Public Contact?Dr Mahbobeh Mesgaran

Arash Wamen's Hospital

mahbobeh.mesgaran@yahoo.com+98 21 7771 9922

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026